In a report released yesterday, Samantha Semenkow from Citi maintained a Buy rating on Catalyst Pharma (CPRX – Research Report), with a price target of $31.00. Discover outperforming stocks and ...

Citi analyst Daniel Grosslight maintained a Buy rating on Cencora (COR – Research Report) today and set a price target of $330.00. The company’s shares closed yesterday at $284.44. Discover ...

April 17 (Reuters) - Citi Research raised its gold price target for the next three months to $3,500 per ounce from $3,200, led by fresh buying from Chinese insurers and safe-haven flows amid ...

After a federal judge ordered Citi to disburse previously awarded EPA funds to climate groups, a panel of appeals court judges in the District of Columbia ruled late Wednesday that Citi must hold onto ...

Citigroup Inc reported on Tuesday that profit rose in the first quarter compared to the same period of the previous year. The company's bottom line came in at $4.064 billion, or $1.96 per share.

Citi Research revises gold price target to $3,500 per ounce. Chinese insurers boost gold purchases, driving demand. Gold investment and industrial demand expected to hit 110% of mine supply. Citi ...

April 17 (Reuters) - Shares of Bank of Queensland (BOQ) (BOQ.AX), opens new tab surged to a more than two-year high on Thursday, as analysts at Citi and Morgan Stanley bet on the stock after the ...

Many or all of the products on this page are from partners who compensate us when you click to or take an action on their website, but this does not influence our evaluations or ratings. Our ...

Although this used to be a common benefit, it’s not anymore. Issuers including American Express, Chase, Citi and Discover dropped the perk entirely. Now, you’ll find it on just a few select ...